• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶介导药物处置动力学。

Dynamics of target-mediated drug disposition.

机构信息

Mathematical Institute, Leiden University, PB 9512, 2300 RA Leiden, The Netherlands.

出版信息

Eur J Pharm Sci. 2009 Dec 8;38(5):445-64. doi: 10.1016/j.ejps.2009.09.007. Epub 2009 Sep 26.

DOI:10.1016/j.ejps.2009.09.007
PMID:19786099
Abstract

We present a mathematical analysis of the basic model underlying target-mediated drug disposition (TMDD) in which a ligand is supplied through an initial bolus or through a constant rate infusion and forms a complex with a receptor (target), which is supplied and removed continuously. Ligand and complex may be eliminated according to first-order processes. We assume that the total receptor pool (free and bound) is constant in time and we give a geometrical description of the evolution of the concentrations of ligand, receptor and receptor-ligand complex which offers a transparent way to compare the full model with simpler models such as the quasi-steady-state (QSS) model, the quasi-equilibrium (QE) model and the empirical Michaelis-Menten (MM) model; we also give precise conditions on the parameters in the TMDD model for the validity of these reduced models. We relate characteristic properties of time courses to parameter regimes and, in particular, we identify and explain non-monotone dependence of the time-to-steady-state on the infusion rate. Finally, we discuss how the volume of the central compartment may be overestimated because of singular initial behaviour of the time course of the ligand concentration.

摘要

我们提出了一个数学分析,用于研究靶介导药物处置(TMDD)的基本模型,其中配体通过初始推注或恒速输注供应,并与受体(靶标)形成复合物,受体持续供应和去除。配体和复合物可根据一级过程消除。我们假设总受体池(游离和结合)在时间上是恒定的,并且给出了配体、受体和受体-配体复合物浓度的演化的几何描述,这为将完整模型与更简单的模型(如准稳态(QSS)模型、准平衡(QE)模型和经验米氏-门限(MM)模型)进行比较提供了一种透明的方法;我们还给出了 TMDD 模型中参数的精确条件,以验证这些简化模型的有效性。我们将时间过程的特征性质与参数范围联系起来,特别是,我们确定并解释了到达稳态时间对输注速率的非单调依赖性。最后,我们讨论了由于配体浓度时间过程的奇异初始行为,中央隔室的体积可能会被高估的问题。

相似文献

1
Dynamics of target-mediated drug disposition.靶介导药物处置动力学。
Eur J Pharm Sci. 2009 Dec 8;38(5):445-64. doi: 10.1016/j.ejps.2009.09.007. Epub 2009 Sep 26.
2
Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics.靶向介导的药物处置模型:模型参数的近似值、可识别性及其在生物药剂学群体药代动力学-药效学建模中的应用。
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):803-12. doi: 10.1517/17425250902992901.
3
Target-mediated drug disposition and dynamics.靶点介导的药物处置与动力学
Biochem Pharmacol. 2006 Jun 28;72(1):1-10. doi: 10.1016/j.bcp.2005.12.041. Epub 2006 Feb 15.
4
Dynamics of target-mediated drug disposition: characteristic profiles and parameter identification.靶向介导药物处置动力学:特征谱和参数辨识。
J Pharmacokinet Pharmacodyn. 2012 Oct;39(5):429-51. doi: 10.1007/s10928-012-9260-6. Epub 2012 Aug 1.
5
Dose correction for the Michaelis-Menten approximation of the target-mediated drug disposition model.米氏方程法中靶介导药物处置模型的剂量校正。
J Pharmacokinet Pharmacodyn. 2012 Apr;39(2):141-6. doi: 10.1007/s10928-011-9233-1. Epub 2012 Jan 4.
6
Approximations of the target-mediated drug disposition model and identifiability of model parameters.靶介导药物处置模型的近似值及模型参数的可识别性。
J Pharmacokinet Pharmacodyn. 2008 Oct;35(5):573-91. doi: 10.1007/s10928-008-9102-8. Epub 2008 Nov 13.
7
Target-mediated drug disposition model for drugs with two binding sites that bind to a target with one binding site.具有两个结合位点且其中一个结合位点与靶点结合的药物的靶点介导药物处置模型。
J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):463-475. doi: 10.1007/s10928-017-9533-1. Epub 2017 Jul 19.
8
Target-mediated drug disposition with drug-drug interaction, Part I: single drug case in alternative formulations.药物-药物相互作用下的靶点介导药物处置,第一部分:不同制剂中的单一药物情况
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):17-26. doi: 10.1007/s10928-016-9501-1. Epub 2017 Jan 10.
9
Target mediated drug disposition with drug-drug interaction, Part II: competitive and uncompetitive cases.药物-药物相互作用下的靶点介导药物处置,第二部分:竞争性和非竞争性情况。
J Pharmacokinet Pharmacodyn. 2017 Feb;44(1):27-42. doi: 10.1007/s10928-016-9502-0. Epub 2017 Jan 10.
10
Target-mediated drug disposition model for drugs that bind to more than one target.针对与多个靶点结合的药物的基于靶点的药物处置模型。
J Pharmacokinet Pharmacodyn. 2010 Aug;37(4):323-46. doi: 10.1007/s10928-010-9163-3. Epub 2010 Jul 29.

引用本文的文献

1
Kinetics of RPR Decline in Pregnant Persons Treated for Syphilis in Pregnancy and Their Infants.孕期梅毒治疗孕妇及其婴儿中快速血浆反应素试验(RPR)滴度下降的动力学
Pathogens. 2024 Nov 17;13(11):1010. doi: 10.3390/pathogens13111010.
2
Improving Pharmacokinetics of Peptides Using Phage Display.利用噬菌体展示技术改善肽的药代动力学
Viruses. 2024 Apr 7;16(4):570. doi: 10.3390/v16040570.
3
Mathematical modeling predicts pathways to successful implementation of combination TRAIL-producing oncolytic virus and PAC-1 to treat granulosa cell tumors of the ovary.
数学建模预测了成功实施联合 TRAIL 产生的溶瘤病毒和 PAC-1 治疗卵巢颗粒细胞瘤的途径。
Cancer Biol Ther. 2023 Dec 31;24(1):2283926. doi: 10.1080/15384047.2023.2283926. Epub 2023 Nov 27.
4
The quest for balance between capturing data and model complexity: A quantitative clinical pharmacology approach applied to monoclonal antibodies.在数据捕获和模型复杂性之间寻求平衡:一种应用于单克隆抗体的定量临床药理学方法。
CPT Pharmacometrics Syst Pharmacol. 2023 May;12(5):639-655. doi: 10.1002/psp4.12927. Epub 2023 Mar 23.
5
A target-mediated drug disposition population pharmacokinetic model of GC1118, a novel anti-EGFR antibody, in patients with solid tumors.一种新型抗 EGFR 抗体 GC1118 在实体瘤患者中的靶向介导药物处置群体药代动力学模型。
Clin Transl Sci. 2021 May;14(3):990-1001. doi: 10.1111/cts.12963. Epub 2021 Jan 25.
6
Application of the Nested Enzyme-Within-Enterocyte (NEWE) Turnover Model for Predicting the Time Course of Pharmacodynamic Effects.嵌套肠细胞内酶周转(NEWE)模型在预测药效时程中的应用。
CPT Pharmacometrics Syst Pharmacol. 2020 Nov;9(11):617-627. doi: 10.1002/psp4.12557. Epub 2020 Sep 28.
7
Geometric singular perturbation analysis of a dynamical target mediated drug disposition model.动态靶点介导药物处置模型的几何奇异摄动分析
J Math Biol. 2019 Jul;79(1):187-222. doi: 10.1007/s00285-019-01354-3. Epub 2019 Apr 10.
8
Asymptotic analysis of a TMDD model: when a reaction contributes to the destruction of its product.一个TMDD模型的渐近分析:当一个反应导致其产物的破坏时。
J Math Biol. 2018 Sep;77(3):821-855. doi: 10.1007/s00285-018-1234-x. Epub 2018 Apr 19.
9
Impact of mathematical pharmacology on practice and theory: four case studies.数学药理学对实践和理论的影响:四个案例研究。
J Pharmacokinet Pharmacodyn. 2018 Feb;45(1):3-21. doi: 10.1007/s10928-017-9539-8. Epub 2017 Sep 7.
10
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic Cancer.抗 PDGFRα 人源单克隆抗体奥雷巴替尼在晚期和/或转移性癌症患者中的群体药代动力学建模。
Clin Pharmacokinet. 2018 Mar;57(3):355-365. doi: 10.1007/s40262-017-0562-0.